Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk

Neurology

Volumn 79, Issue 6, 2012, Pages 538-546

  Nolan, David ^a,b   Castley, Alison ^a   Tschochner, Monika ^b   James, Ian ^b   Qiu, Wei ^c   Sayer, David ^d   Christiansen, Frank T ^a,e   Witt, Campbell ^a,e   Mastaglia, Frank ^e,f   Carroll, William ^e,f   Kermode, Allan ^e,f  

^a ROYAL PERTH HOSPITAL   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c SUN YAT SEN UNIVERSITY   (China)

^d Conexio Genomics ^*  (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB1 ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; SEROLOGY; VITAMIN D RESPONSIVE ELEMENT;

EID: 84866107681     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318263c407     Document Type: Article

References (27)

1. Davenport CB. Multiple sclerosis from the standpoint of geographic distribution and race. In: Association for Research in Nervous and Mental Diseases, vol 2. New York: Herber; 1921:8 -19.
2. Ramagopalan SV, Handel AE, Giovannoni G, Rutherford Siegel S, Ebers GC, Chaplin G. Relationship of UV exposure to prevalence of multiple sclerosis in England. Neurology 2011;76:1410 -1414.
3. Orton SM, Wald L, Confavreux C, et al. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 2011;76:425-431.
4. McLeod JG, Hammond SR, Kurtzke JF. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment: I: risk of MS by age at immigration. J Neurol 2011;258:1140 -1149.
5. Staples J, Ponsonby AL, Lim L. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ 2010;340:c1640.
6. Ramagopalan SV, Link J, Byrnes JK, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009; 73:2107-2111.
7. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62:60-65.
8. Peelen E, Knippenberg S, Muris AH, et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 2011;10:733-743.
9. Baeke F, Korf H, Overbergh L, et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010;121:221-227.
10. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010;20:1352-1360.
11. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC Class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;5:e1000369.
12. Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 2007;165:1097-1109.
13. Israni N, Goswami R, Kumar A, Rani R. Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One 2009;4:e8023.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
15. Compston A, Edan G, Goodkin D, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
16. Sayer D, Whidborne R, Brestovac B, Trimboli F, Witt C, Christiansen F. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 2001;57:46 -54.
17. Bray RA, Hurley CK, Kamani NR, et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant 2008;14(9 suppl):45-53.
18. Sindwani S, Singal DP. Polymorphism in the Y box controls level of cytokine-mediated expression of HLA-DRB1 genes. Tissue Antigens 2001;58:315-323.
19. Svensson AC, Setterblad N, Pihlgren U, Rask L, Andersson G. Evolutionary relationship between human major histocompatibility complex HLA-DR haplotypes. Immunogenetics 1996;43:304 -314.
20. Greenbaum J, Sidney J, Chung J, Brander C, Peters B, Sette A. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 2011;63:325-335.
21. Gu X, Nei M. Locus specificity of polymorphic alleles and evolution by a birth-and-death process in mammalian MHC genes. Mol Biol Evol 1999;16:147-156.
22. Emery P, Mach B, Reith W. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum Immunol 1993;38:137-147.
23. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2009;37(database issue):D1006-D1012.
24. Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimaki T. The combination of HLA-DR1 and HLA-DR53 protects against MS. Neurology 2001;56:383-385.
25. Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009;18:261-266.
26. Vogt AB, Kropshofer H, Kalbacher H, et al. Ligand motifs of HLA-DRB5-0101 and HLA-DRB1-1501 molecules delineated from self-peptides. J Immunol 1994;153:1665-1673.
27. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214 -219.